Literature DB >> 10935492

Transcriptional inhibition of matrix metalloproteinase 9 (MMP-9) activity by a c-fos/estrogen receptor fusion protein is mediated by the proximal AP-1 site of the MMP-9 promoter and correlates with reduced tumor cell invasion.

D L Crowe1, T N Brown.   

Abstract

Tumor cell invasion of basement membranes is one of the hallmarks of malignant transformation. Tumor cells secrete proteolytic enzymes known as matrix metalloproteinases (MMPs) which degrade extracellular matrix molecules. Increased expression of MMP-9 has been associated with acquisition of invasive phenotype in many tumors. However, multiple mechanisms for regulation of MMP-9 gene expression by tumor cell lines have been proposed. A number of transcription factor binding sites have been characterized in the upstream regulatory region of the MMP-9 gene, including those for AP-1. To determine how a specific AP-1 family member, c-fos, regulates MMP-9 promoter activity through these sites, we used an expression vector containing the c-fos coding region fused to the estrogen receptor (ER) ligand binding domain. This construct is activated upon binding estradiol. Stable expression of this construct in ER negative squamous cell carcinoma (SCC) lines produced an estradiol dependent decrease in the number of cells that migrated through a reconstituted basement membrane. This decreased invasiveness was accompanied by estradiol dependent downregulation of MMP-9 activity as determined by gelatin zymography. Estradiol also produced transcriptional downregulation of an MMP-9 promoter construct in cells transiently transfected with the c-fosER expression vector. This downregulation was mediated by the AP-1 site at -79 bp in the MMP-9 promoter. We concluded that the proximal AP-1 site mediated the transcriptional downregulation of the MMP-9 promoter by a conditionally activated c-fos fusion protein.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10935492      PMCID: PMC1508097          DOI: 10.1038/sj.neo.7900041

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  21 in total

1.  Structure of the human type IV collagenase gene.

Authors:  P Huhtala; L T Chow; K Tryggvason
Journal:  J Biol Chem       Date:  1990-07-05       Impact factor: 5.157

Review 2.  Tumor invasion and metastases--role of the extracellular matrix: Rhoads Memorial Award lecture.

Authors:  L A Liotta
Journal:  Cancer Res       Date:  1986-01       Impact factor: 12.701

3.  Type IV collagenolytic activity linkage with the metastatic phenotype induced by ras transfection.

Authors:  S Garbisa; A Negro; T Kalebic; R Pozzatti; R Muschel; U Saffiotti; L A Liotta
Journal:  Adv Exp Med Biol       Date:  1988       Impact factor: 2.622

4.  The rabbit gene for 92-kDa matrix metalloproteinase. Role of AP1 and AP2 in cell type-specific transcription.

Authors:  M E Fini; J D Bartlett; M Matsubara; W B Rinehart; M K Mody; M T Girard; M Rainville
Journal:  J Biol Chem       Date:  1994-11-18       Impact factor: 5.157

5.  Mr 92,000 gelatinase release correlates with the metastatic phenotype in transformed rat embryo cells.

Authors:  E J Bernhard; R J Muschel; E N Hughes
Journal:  Cancer Res       Date:  1990-07-01       Impact factor: 12.701

6.  v-Src activates the expression of 92-kDa type IV collagenase gene through the AP-1 site and the GT box homologous to retinoblastoma control elements. A mechanism regulating gene expression independent of that by inflammatory cytokines.

Authors:  H Sato; M Kita; M Seiki
Journal:  J Biol Chem       Date:  1993-11-05       Impact factor: 5.157

7.  Activation of an inducible c-FosER fusion protein causes loss of epithelial polarity and triggers epithelial-fibroblastoid cell conversion.

Authors:  E Reichmann; H Schwarz; E M Deiner; I Leitner; M Eilers; J Berger; M Busslinger; H Beug
Journal:  Cell       Date:  1992-12-24       Impact factor: 41.582

8.  Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells.

Authors:  H Sato; M Seiki
Journal:  Oncogene       Date:  1993-02       Impact factor: 9.867

9.  Stimulation of the 92-kD type IV collagenase promoter and enzyme expression in human melanoma cells.

Authors:  M A Lauricella-Lefebvre; V Castronovo; H Sato; M Seiki; D L French; M P Merville
Journal:  Invasion Metastasis       Date:  1993

10.  Activity of type IV collagenases in benign and malignant breast disease.

Authors:  B Davies; D W Miles; L C Happerfield; M S Naylor; L G Bobrow; R D Rubens; F R Balkwill
Journal:  Br J Cancer       Date:  1993-05       Impact factor: 7.640

View more
  20 in total

1.  Sirt1: A Guardian of the Development of Diabetic Retinopathy.

Authors:  Manish Mishra; Arul J Duraisamy; Renu A Kowluru
Journal:  Diabetes       Date:  2018-01-08       Impact factor: 9.461

2.  Kaposi's sarcoma-associated herpesvirus induction of AP-1 and interleukin 6 during primary infection mediated by multiple mitogen-activated protein kinase pathways.

Authors:  Jianping Xie; Hongyi Pan; Seungmin Yoo; Shou-Jiang Gao
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

3.  Jun N-terminal kinase 1 mediates transcriptional induction of matrix metalloproteinase 9 expression.

Authors:  D L Crowe; K J Tsang; B Shemirani
Journal:  Neoplasia       Date:  2001 Jan-Feb       Impact factor: 5.715

4.  Estrogen-related abnormalities in glomerulosclerosis-prone mice: reduced mesangial cell estrogen receptor expression and prosclerotic response to estrogens.

Authors:  Mylène Potier; Michael Karl; Feng Zheng; Sharon J Elliot; Gary E Striker; Liliane J Striker
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

5.  Effects of streptolysin o on extracellular matrix gene expression in normal human epidermal keratinocytes.

Authors:  Stephen W Mamber; Volkan Gurel; Ryan G Rhodes; John McMichael
Journal:  Dose Response       Date:  2011-03-14       Impact factor: 2.658

6.  Envelope gene-mediated neurovirulence in feline immunodeficiency virus infection: induction of matrix metalloproteinases and neuronal injury.

Authors:  J B Johnston; C Silva; C Power
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

7.  Inhibition of transcriptional activity of c-JUN by SIRT1.

Authors:  Zhanguo Gao; Jianping Ye
Journal:  Biochem Biophys Res Commun       Date:  2008-09-26       Impact factor: 3.575

8.  Kaposi's sarcoma-associated herpesvirus promotes angiogenesis by inducing angiopoietin-2 expression via AP-1 and Ets1.

Authors:  Feng-Chun Ye; David J Blackbourn; Michael Mengel; Jian-Ping Xie; Li-Wu Qian; Whitney Greene; I-Tien Yeh; David Graham; Shou-Jiang Gao
Journal:  J Virol       Date:  2007-02-07       Impact factor: 5.103

9.  Brain-derived neurotrophic factor induces matrix metalloproteinase 9 expression in neurons via the serum response factor/c-Fos pathway.

Authors:  Bozena Kuzniewska; Emilia Rejmak; Anna R Malik; Jacek Jaworski; Leszek Kaczmarek; Katarzyna Kalita
Journal:  Mol Cell Biol       Date:  2013-03-18       Impact factor: 4.272

10.  Hypertension and Estrogen Deficiency Augment Aneurysmal Remodeling in the Rabbit Circle of Willis in Response to Carotid Ligation.

Authors:  Vincent M Tutino; Max Mandelbaum; Akira Takahashi; Liza C Pope; Adnan Siddiqui; John Kolega; Hui Meng
Journal:  Anat Rec (Hoboken)       Date:  2015-08-21       Impact factor: 2.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.